PT  - JOURNAL ARTICLE
AU  - Sofi-Mahmudi, Ahmad
AU  - Iranparvar, Pouria
AU  - Shakiba, Maryam
AU  - Shamsoddin, Erfan
AU  - Mohammad-Rahimi, Hossein
AU  - Naseri, Sadaf
AU  - Motie, Parisa
AU  - Mesgarpour, Bita
TI  - Quality assessment of studies included in Cochrane oral health systematic reviews
AID  - 10.1101/2020.10.10.20210518
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.10.20210518
4099  - http://medrxiv.org/content/early/2020/10/11/2020.10.10.20210518.short
4100  - http://medrxiv.org/content/early/2020/10/11/2020.10.10.20210518.full
AB  - Objectives The Risk of Bias (RoB) and other characteristics of randomized clinical trials included in Cochrane oral health systematic reviews were assessed.Study Design and Settings All the trials included in Cochrane oral health systematic reviews were examined. The RoB was evaluated for all the included clinical trials according to the Cochrane review standards. The Overall Risk of Bias (ORoB) was defined in this study based on the criteria for determining the overall bias in Cochrane’s RoB tool-v2. Descriptive analyses were carried out to determine the frequency of each intended variable.Results A total of 2565 studies were included in our analysis. The majority of the studies (n=1600) had sample sizes of 50 or higher. As for blinding, 907 studies were labelled as double-blind. Performance bias showed the highest rate of high risk (31.4%). Almost half of the studies had a high ORoB compared to 11.1% with low ORoB. The studies that used placebos had higher low ORoB (14.8% vs. 10.7%). The double-blind studies had the highest low ORoB (23.6%). The studies with a cross-over design had the highest low ORoB (28.8%).Conclusion Overall, the RoB for the studies on dentistry and oral health in Cochrane reviews was deemed high.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NIMADAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available at: https://doi.org/10.6084/m9.figshare.13070135.v2https://doi.org/10.6084/m9.figshare.13070135.v2